Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAib Group Regulatory News (AIBG)

Share Price Information for Aib Group (AIBG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 446.00
Bid: 441.00
Ask: 447.50
Change: 5.00 (1.13%)
Spread: 6.50 (1.474%)
Open: 446.00
High: 446.00
Low: 446.00
Prev. Close: 441.00
AIBG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIB Group plc Q1 2021 Trading Update

6 May 2021 07:00

RNS Number : 7546X
AIB Group PLC
06 May 2021
 

 

 

EMBARGO 07:00

06 May 2021

 

AIB Group pLC - Q1 2021 Trading update (UNAUDITED)

Return to profitability in Q1 2021; Trading in line with expectations

 

"I am pleased to report that the Group returned to profitability in the first quarter of 2021 and we are confident of achieving our 2021 full year guidance. As we look to the remainder of the year, we expect a strong recovery as the economy re-opens and the roll-out of vaccines gathers momentum. The implementation of our strategy is well underway and positions us well for the future. As our industry undergoes significant change, our strategic clarity gives us confidence that our strong balance sheet, digital capability, distribution and franchise will enable us to grow, serving our customers and the communities in which we operate. As previously announced, we are progressing a number of acquisition opportunities to complement our existing strong customer propositions. We look forward to updating the market on these initiatives at the appropriate time later in the year. As Ireland emerges from lockdown and the vaccine roll-out continues, we are confident about the outlook and our ability to generate sustainable shareholder returns and meet our medium-term targets by 2023."

- Colin Hunt, Chief Executive Officer

 

Q1 key highlights: (all comparisons versus Q1 2020 unless otherwise stated)

· Profitability restored in Q1 with current trading in line with expectations

· Confident for the remainder of 2021; full year guidance reiterated(1)

· Total income decreased 4%; resilient revenues supported by diversified income streams

o Net interest income decreased 13%; Other income increased 36%

· Continued focus on cost discipline; strategic cost initiatives on track

o Stable operating expenses; FTEs declined 1% since Dec 20 to 9,116

· Net credit impairment charge of c. €50m; Q1 annualised cost of risk c. 35bps

· Performing loans of €55.3bn, up €0.2bn since Dec 20; new lending of €2.3bn down 7%

· NPEs down to €3.8bn or 6.5% of gross loans (Dec 20: €4.3bn or 7.3%) post NPE portfolio sales

· Customer deposits of €84.5bn; increased 3% from Dec 20 as savings continue to accumulate

· Fully loaded CET1 of 15.8%, up 0.2% from Dec 20; well ahead of >14% target

· First Irish company to commit to use World Economic Forum Stakeholder Capitalism metrics

· Well-positioned as the Irish economy re-opens and the banking landscape evolves

 

Financial Performance

 

The Group recorded a profit in the first quarter of 2021 and is on track to deliver a performance in line with expectations for the full year.

 

Net interest income (NII) as anticipated was 13% lower in Q1 versus Q1 2020 while momentum gathers on NII recovery through our negative interest rate strategy. Since the year-end, deposits at negative rates increased from €4.7bn to €8bn at the end of Q1 and to c. €10bn currently. NIM in the quarter was 1.66%, 4bps lower than the Q4 20 exit NIM of 1.70%. No funding benefit, from the €4bn TLTRO drawn down in September 2020, has been included in Q1 pending verification that the relevant lending benchmark has been achieved. Our appetite to draw down further TLTRO in June 2021, up to our limit of c. €9bn, is influenced by a number of factors including the timing and completion of inorganic initiatives. We reiterate our guidance that we expect a moderate decline in NII in 2021.

 

Q1 2021 net fee and commission income of €103m was in line with a normalised quarterly run-rate, demonstrating resilient customer activity in the first quarter. Other items within other income benefited from positive valuation movements. We expect full year 2021 other income to be broadly in line with 2020.

 

Q1 2021 costs were broadly similar to Q1 2020 with lower staff costs offset by a rise in depreciation as expected. The focus on efficiency continues as FTE numbers declined by 1% to 9,116 since December 20. For the full year, costs are expected to decline marginally and we are on track to achieve our medium-term target of < €1.35bn(2) by 2023.

 

Regulatory costs and levies for 2021, including the Single Resolution Fund, the Deposit Guarantee Scheme and the Bank Levy, are expected to be c. €120m for the full year.

 

A net credit impairment charge was recorded in Q1 of c. €50m representing an annualised cost of risk of c. 35bps. Macroeconomic scenarios will be updated as part of the half-year credit impairment process. With positive trends emerging and the return to a more normalised credit environment, we expect our full year cost of risk to be at or below our previous guidance of c. 40bps.

 

We expect to incur exceptional costs in 2021 of c. €250m including costs relating to business restructuring, voluntary severance and the ongoing operational costs of the tracker mortgage programme.

 

Balance sheet

 

Gross loans of €59.2bn were down €0.3bn in the quarter (Dec 20: €59.5bn) primarily driven by NPE portfolio sales and the continuing trend of redemptions exceeding new lending. These impacts were partly offset by positive FX movements, which also contributed to a marginal increase in the performing loan book to €55.3bn.

 

In Q1 total new lending of €2.3bn (-7% versus Q1 20) was recorded with mixed trends across segments, with sluggish demand in consumer lending and stronger activity in corporate sectors.

 

The Irish mortgage market performed strongly in Q1 2021 with total drawdowns up 7% on Q1 2020. A solid rise in mortgage lending is expected with market estimates revised to c. €10bn for 2021. AIB ROI new mortgage lending was €0.5bn in the quarter. The Q1 pipeline shows strong applications and approvals data both at market level and AIB's share thereof, giving us confidence in our full year performance.

 

The Q1 lockdown impacted consumer credit demand which led to a 30% decline in new ROI personal lending versus Q1 2020. In contrast, household deposits have continued to increase while credit card debt and overdrafts declined. We expect this trend to reverse on the re-opening of the economy, as discretionary spend increases, as seen in Q3 2020. The SME sector, supported by government measures, remained resilient and we recorded a 3% increase in new lending versus Q1 2020. CIB(3) had a good start to the year, particularly in the renewable energy sector and corporate banking. New lending in the UK was up 8%.

 

We continue to support our customers with the transition to a lower-carbon economy and green lending accounted for 21% of total new lending whilst our green mortgage product represented c. 15% of new ROI mortgage lending.

 

NPEs decreased to €3.8bn or 6.5% of gross loans (Dec 20: €4.3bn or 7.3%) primarily due to €0.7bn of portfolio sales. In terms of stage migration, there has been minimal net flow to Stage 3. Of the c. 66,000 payment breaks provided in Retail Banking, effectively all have concluded and, consistent with our previous update, 88% have returned to and maintained full capital and interest payments.(4)

 

The loan to deposit ratio was 67% at the end of Q1 2021. Customer accounts of €84.5bn increased from €82bn at December 2020 due to the continued high levels of savings.

 

Capital

 

The fully loaded CET1 at the end of Q1 was 15.8% (Dec 20: 15.6%) which is well ahead of our medium-term target of >14%. The 0.2% increase since December was driven by Q1 profit and positive calendar provisioning impact (due to NPE portfolio sales) partially offset by normal capital deductions. Our strong capital position enables us both to invest in our business and pursue RoTE accretive inorganic opportunities and over time resume distributions to shareholders.

 

Strategy 2023 and Outlook

 

Strategic progress

Implementation of our strategic plan continues and we are making good progress in advancing our digitalisation and ways of working programmes. Having initiated a sales process earlier this year, we are reviewing exit options in relation to our GB SME business.

 

Regarding inorganic initiatives, the regulatory approval process is underway for the acquisition of Goodbody and our joint venture proposition with Great-West LifeCo is progressing well. Both businesses will enhance our product suite for customers and diversify our revenues. Commercial negotiations with NatWest Holdings Limited, for the acquisition of a c. €4bn performing corporate and commercial loan portfolio, have progressed constructively and we will update the market in due course.

 

Sustainability

We are proud to be the first Irish company to have committed to use World Economic Forum Stakeholder Capitalism metrics in our reporting, joining 78 other sustainability-focused companies globally. The Forum's Stakeholder Capitalism metrics are based on the four value-driven principles of People, Planet, Prosperity and Governance. This commitment reflects our pledge to lead with purpose and to seek long-term value creation by adopting a multi-stakeholder approach. Additionally we are the first Irish bank to join the UN Net Zero Banking Alliance. In April we received an ESG rating upgrade from Sustainalytics. With an improved low risk ESG score of 14.5, AIB ranks 53rd out of 1,047 banks globally which benchmarks very favourably to our peer group and demonstrates AIB's significant progress in advancing the Sustainability agenda.

 

Outlook

Following a return to profitability in the first quarter and the phased re-opening of the economy, we are confident for the remainder of the year as we focus on implementing our strategy and supporting our customers. We remain comfortable with the guidance provided to the market at our full year results in March 2021 and outlined above. For clarity, this guidance excludes the impact of any inorganic initiatives and we will provide a further update at our half year results on 4 August 2021.

 

Note: Figures presented above may be subject to rounding and thereby differ to the 2020 Annual Financial Report

(1) Guidance excludes impact of inorganic opportunities

(2) Costs before bank levies and regulatory fees and exceptional items

(3) CIB: Corporate, Institutional and Business Banking

(4) Return to full capital and interest (88%) reflects those customers who are performing and making full repayments post-payment break. It excludes those in arrears management (5%), forbearance (4%) or NPE (3%) processes - not all these customer will require forbearance as many are resolved through business as usual customer engagement. Data as at 23 April 2021

-ENDS-

 

For further information, please contact:

Niamh Hore / Janet McConkey

Paddy McDonnell

Investor Relations

Media Relations

AIB Group

AIB Group

Dublin

Dublin

Tel: +353-1-6411817 / +353-1-6418974

Tel: +353-87-7390743

email: niamh.a.hore@aib.ie

janet.e.mcconkey@aib.ie

email: paddy.x.mcdonnell@aib.ie

 

 

Forward Looking Statements

 

This document contains certain forward looking statements with respect to the financial condition, results of operations and business of AIB Group and certain of the plans and objectives of the Group. These forward looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward looking statements sometimes use words such as 'aim', 'anticipate', 'target', 'expect', 'estimate', 'intend', 'plan', 'goal', 'believe', 'may', 'could', 'will', 'seek', 'continue', 'should', 'assume', or other words of similar meaning. Examples of forward looking statements include, among others, statements regarding the Group's future financial position, capital structure, Government shareholding in the Group, income growth, loan losses, business strategy, projected costs, capital ratios, estimates of capital expenditures, and plans and objectives for future operations. Because such statements are inherently subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward looking information. By their nature, forward looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. There are a number of factors that could cause actual results and developments to differ materially from those expressed or implied by these forward looking statements. These are set out in the Principal risks on pages 50 to 53 in the 2020 Annual Financial Report. In addition to matters relating to the Group's business, future performance will be impacted by direct and indirect impacts of the COVID-19 pandemic and by Irish, UK and wider European and global economic and financial market considerations. Any forward looking statements made by or on behalf of the Group speak only as of the date they are made. The Group cautions that the list of important factors on pages 50 to 53 of the 2020 Annual Financial Report is not exhaustive. Investors and others should carefully consider the foregoing factors and other uncertainties and

events when making an investment decision based on any forward looking statement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEASSKESXFEEA
Date   Source Headline
21st Dec 20217:13 amRNSAIB - State's intention to sell part shareholding
21st Dec 20217:00 amRNSIntention to sell shares in AIB Group Plc
25th Nov 20219:00 amRNSChange in Director Details
23rd Nov 20217:00 amRNSAIB announces sale of SME portfolio in GB
3rd Nov 20217:00 amRNSAIB Group plc - Q3 2021 Trading Update
28th Oct 20219:30 amRNSAppointment of Chair
14th Oct 20215:11 pmRNSAIB - sale of non-performing loan portfolio
5th Oct 202110:00 amRNSAIB confirms date for Q3 2021 Trading Update
14th Sep 202111:00 amRNSAppointment of Directors
1st Sep 20217:00 amRNSAIB - acquisition of Goodbody completion
6th Aug 202112:30 pmRNSNotification of Transaction by PDMR and PCA
4th Aug 20217:00 amRNSAIB - Half-Yearly Financial Results 2021
30th Jul 20215:28 pmRNSAIB Group plc – EBA European-Wide Stress Test 2021
30th Jun 20213:00 pmRNSAIB Group confirms date for HY21 Financial Results
28th Jun 20217:02 amRNSAIB acquisition of EUR4.2bn Ulster Bank loans
25th Jun 202111:00 amRNSNotification of Major Holdings
23rd Jun 20215:36 pmRNSAIB forms JV with Great-West Lifeco
18th Jun 202110:00 amRNSAppointment of Director
28th May 202111:00 amRNSAppointment of Executive Director
11th May 202112:00 pmRNSStabilisation Notice
10th May 20218:26 amRNSStabilisation Notice
6th May 20213:30 pmRNSResults of AGM 2021
6th May 20217:00 amRNSAIB Group plc Q1 2021 Trading Update
20th Apr 20211:04 pmRNSAIB confirms date for Q1 2021 Trading Update
1st Apr 20213:00 pmRNSNotice of Annual General Meeting 2021
29th Mar 202112:00 pmRNSChange in Director Details
16th Mar 20214:45 pmRNSChange in Director Details
15th Mar 20213:00 pmRNSAppointment of Director
11th Mar 202111:00 amRNSUpdate on Migration from CREST to Euroclear Bank
10th Mar 20219:30 amRNSNotification of Transaction by PDMR
8th Mar 202110:20 amRNSNotification of Transaction by PDMR
5th Mar 20217:00 amRNSAIB Group plc - 2020 Annual Financial Results
2nd Mar 20212:00 pmRNSAIB Group plc - Acquisition of Goodbody
19th Feb 20217:12 amRNSAIB – Sale of non-performing loan portfolio
19th Feb 20217:10 amRNSAIB-potential acq Ulster Bk's Corp & Comm loan bk
5th Feb 202112:00 pmRNSResults of Extraordinary General Meeting
22nd Jan 202110:00 amRNSAppointment of Director
14th Jan 202110:00 amRNSNotice of Results - AIB to publish on 5 March 2021
11th Jan 20213:00 pmRNSNotice of Extraordinary General Meeting
30th Dec 20207:00 amRNSAIB Group plc - Currency Change on LSE
22nd Dec 202012:30 pmRNSForm 8.3 - Studio Retail Group plc
8th Dec 20202:52 pmRNSNotification of Major Holdings
2nd Dec 20207:00 amRNSAIB Group plc Medium-Term Targets
5th Nov 20207:00 amRNSDirectorate Change
30th Oct 20207:00 amRNSTrading Statement
7th Oct 202012:39 pmRNSAIB announces date for Q3 2020 Trading Update
2nd Oct 20201:29 pmRNSStabilisation Notice
23rd Sep 202010:28 amRNSStabilisation Notice
4th Sep 20205:53 pmRNSAIB Group plc H1 2020 Pillar 3 Report
13th Aug 202010:00 amRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.